ClinVar Miner

Submissions for variant NM_002529.4(NTRK1):c.1860_1861insT (p.Pro621fs)

dbSNP: rs80356676
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000479042 SCV000565335 pathogenic not provided 2022-11-03 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34405299, 28328124, 18955016, 10861667, 31841741, 32056211, 20301726, 34732685)
Baylor Genetics RCV000020469 SCV001520941 pathogenic Hereditary insensitivity to pain with anhidrosis 2019-09-05 criteria provided, single submitter clinical testing This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing in multiple individuals [PMID: 18955016, 10861667, 28328124, ClinVar ID: 21306]
Labcorp Genetics (formerly Invitae), Labcorp RCV000020469 SCV002237779 pathogenic Hereditary insensitivity to pain with anhidrosis 2021-09-01 criteria provided, single submitter clinical testing
3billion, Medical Genetics RCV000020469 SCV002573044 pathogenic Hereditary insensitivity to pain with anhidrosis 2022-09-01 criteria provided, single submitter clinical testing The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000021306 / PMID: 10861667). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Institute of Human Genetics, University of Leipzig Medical Center RCV000020469 SCV004027677 pathogenic Hereditary insensitivity to pain with anhidrosis 2023-05-03 criteria provided, single submitter clinical testing Criteria applied: PVS1,PM3_STR,PM2_SUP
Genome-Nilou Lab RCV000020469 SCV004048753 pathogenic Hereditary insensitivity to pain with anhidrosis 2023-04-11 criteria provided, single submitter clinical testing
OMIM RCV000020469 SCV000033349 pathogenic Hereditary insensitivity to pain with anhidrosis 2000-06-19 no assertion criteria provided literature only
GeneReviews RCV000020469 SCV000040902 not provided Hereditary insensitivity to pain with anhidrosis no assertion provided literature only Founder variant in Israeli Bedouins

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.